M
Maria Agapova
Researcher at University of Washington
Publications - 13
Citations - 307
Maria Agapova is an academic researcher from University of Washington. The author has contributed to research in topics: Cost effectiveness & Population. The author has an hindex of 8, co-authored 13 publications receiving 280 citations. Previous affiliations of Maria Agapova include Systems Research Institute.
Papers
More filters
Journal ArticleDOI
The cost-effectiveness of pathogen reduction technology as assessed using a multiple risk reduction model.
TL;DR: The health economics of PRT could be an important consideration in decision making for this technology because of the potential broad‐spectrum risk reduction capability ofPRT.
Journal ArticleDOI
Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi
Brian Custer,Maria Agapova,Roberta Bruhn,Robin Cusick,Hany Kamel,Peter Tomasulo,Hope H. Biswas,Leslie H. Tobler,Tzong-Hae Lee,Sally Caglioti,Michael P. Busch +10 more
TL;DR: The objective of this study was to report the results of routine testing and risk factor data from allogeneic blood donors.
Journal ArticleDOI
Cost-effectiveness of screening the US blood supply for Trypanosoma cruzi.
TL;DR: The cost‐effectiveness of seven testing strategies was evaluated against no testing and hierarchically in incremental analysis, and component‐specific strategies are based on screening platelet‐containing donations.
Journal ArticleDOI
Erratum to “Cancer Incidence and Mortality in a Cohort of US Blood Donors: A 20-Year Study”
TL;DR: In the original paper, there was an error in the legend for Figure 3, donor and nondonor lines were reversed and the legend is provided with the correct legend.
Journal ArticleDOI
Association between HLA class I and class II alleles and the outcome of West Nile virus infection: an exploratory study.
Marion C. Lanteri,Zhanna Kaidarova,Trevor Peterson,Steven Cate,Brian Custer,Brian Custer,Brian Custer,Shiquan Wu,Maria Agapova,Jacqueline P. Law,Thomas Bielawny,Frank Plummer,Frank Plummer,Leslie H. Tobler,Mark Loeb,Michael P. Busch,Michael P. Busch,Jonathan L. Bramson,Ma Luo,Ma Luo,Philip J. Norris,Philip J. Norris +21 more
TL;DR: Host HLA may be associated with the outcome of WNV disease; HLA-A*68 and C*08 might function as “susceptible” alleles, whereas H LA-B*40 and C-03 might functionAs “protective”alleles.